Mirae Asset Global Investments Co., Ltd. Protagonist Therapeutics, Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,986 shares of PTGX stock, worth $111,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,986
Previous 2,130
6.76%
Holding current value
$111,116
Previous $95,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58.9MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$332 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$322 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$308 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$236 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$186 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.75B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...